Open AccessPrevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices
Author(s) -
Scott D. Ramsey,
Joseph M. Unger,
Laurence H. Baker,
Richard F. Little,
Rohit Loomba,
Jessica Hwang,
Rashmi Chugh,
Monica A. Konerman,
Kathryn B. Arnold,
Alex R. Menter,
E D Thomas,
Ross M. Michels,
Carla Walker Jorgensen,
Gary V. Burton,
Nishin A. Bhadkamkar,
Dawn L. Hershman
Publication year - 2019
Publication title -
jama oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.846
H-Index - 99
eISSN - 2374-2445
pISSN - 2374-2437
DOI - 10.1001/jamaoncol.2018.6437
Subject(s) - medicine , hepatitis b virus , cancer , hepatitis c virus , hepatitis b , cohort , hepatitis c , cohort study , oncology , virus , immunology
Universal screening of patients with newly diagnosed cancer for hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV is not routine in oncology practice, and experts disagree about whether universal screening should be performed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom